Overlapping network meta-analyses on psoriasis systemic treatments: an overview, quantity does not make quality - Université de Rennes Accéder directement au contenu
Article Dans Une Revue British Journal of Dermatology Année : 2022

Overlapping network meta-analyses on psoriasis systemic treatments: an overview, quantity does not make quality

Résumé

BACKGROUND: Network Meta-analyses (NMAs) have become successful in addressing gaps in the comparative effectiveness of systemic treatments in moderate-to-severe psoriasis. However, their increasing number carries both a risk of overlap and reproducibility issues that can hamper clinical decision-making. In this overview, we aimed to assess redundancy across these NMAs and to describe their characteristics. METHODS: We considered all systematic reviews with NMAs of randomized controlled trials that included adult patients with moderate-to-severe psoriasis and that evaluated the efficacy and/or safety of systemic treatments compared with placebo or with an active comparator. PubMed/MEDLINE, Epistemonikos, PROSPERO and the Evidence Update of the Centre of Evidence-Based Dermatology of the University of Nottingham were searched up to 25 February 2021. Our main outcome was the number per year of redundant NMAs and the extent of their overlap. We also described their features, especially, the confidence in the results of the reviews, the studies’ funding and the presence of spin (a description that overstates efficacy and/or understates harm), reporting issues and methodological characteristics. RESULTS: In total, 47 redundant NMAs were included. Only 2/47 (4%) included all available treatments. Both efficacy and safety were evaluated in 14/47 (30%) NMAs and both short and long-term evaluations were assessed in 5/47 (11 %). Confidence in the results was critically low for 39/47 (83%) NMAs and only 10/47 (23 %) registered a protocol. 26/47 NMAs (55%) received pharmaceutical funding. CROs were involved in 19/47 (40%) NMAs. Reporting was poor across most of the NMAs’ abstracts and spin was present in all of the abstracts. Almost half of the NMA failed to consider important limitations such as heterogeneity (32%) or consistency (66%). DISCUSSION: In addition to a duplication of efforts, our overview showed heterogeneous methods and poor confidence in the results in a majority of the included NMAs, further distorted by reporting issues and spin. Clinicians need to interpret NMAs with caution when looking for the most reliable and comprehensive evidence.
Fichier principal
Vignette du fichier
Guelimi et al-2021-Overlapping network meta-analyses on psoriasis systemic treatments.pdf (9.47 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03513874 , version 1 (07-01-2022)

Licence

Paternité - Pas d'utilisation commerciale

Identifiants

Citer

R Guelimi, S Afach, J-P Régnaux, T Bettuzzi, G Chaby, et al.. Overlapping network meta-analyses on psoriasis systemic treatments: an overview, quantity does not make quality. British Journal of Dermatology, 2022, 187 (1), pp.29-41. ⟨10.1111/bjd.20908⟩. ⟨hal-03513874⟩
133 Consultations
124 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More